资金流向方面，主力资金净流出97.94万元，大单买入0.00元，占比0.00%，卖出97.94万元，占比 6.62%。 同德化工今年以来股价涨10.16%，近5个交易日跌0.91%，近20日涨3.04%，近60日跌0.18%。 今年以来同德化工已经1次登上龙虎榜，最近一次登上龙虎榜为7月23日，当日龙虎榜净买入-3130.28万 元；买入总计4663.82万元 ，占总成交额比9.58%；卖出总计7794.10万元 ，占总成交额比16.00%。 资料显示，山西同德化工股份有限公司位于山西省河曲县文笔镇焦尾城大茂口，成立日期2001年6月10 日，上市日期2010年3月3日，公司主营业务涉及制造销售硝铵、乳化、粉乳炸药、二氧化硅系列产品、 助剂产品、工程爆破设计施工及爆破技术咨询服务(限分支机构使用)、进出口本企业所需的原辅材料、 仪器、仪表及零配件(国家禁止进品的品种除外)并为本企业生产的产品使用技术咨询服务、售后服务。 主营业务收入构成为：工程爆破58.58%，工业炸药27.98%，其他民爆器材10.46%，供应链服务1.10%， 运输服务0.72%，电力业务0.62%，其他0.54%。 11月19日，同德化 ...

11月19日，雅化集团盘中上涨2.20%，截至09:37，报25.07元/股，成交4.71亿元，换手率1.76%，总市值 288.95亿元。 资金流向方面，主力资金净流入1313.46万元，特大单买入4678.79万元，占比9.94%，卖出1811.36万 元，占比3.85%；大单买入8468.79万元，占比17.99%，卖出1.00亿元，占比21.29%。 雅化集团今年以来股价涨115.01%，近5个交易日涨24.91%，近20日涨59.99%，近60日涨77.42%。 今年以来雅化集团已经4次登上龙虎榜，最近一次登上龙虎榜为11月17日，当日龙虎榜净买入2288.69万 元；买入总计4.03亿元 ，占总成交额比16.34%；卖出总计3.80亿元 ，占总成交额比15.41%。 资料显示，四川雅化实业集团股份有限公司位于四川省成都市高新区天府四街66号航兴国际广场1号楼 21层-23层，成立日期2001年12月25日，上市日期2010年11月9日，公司主营业务涉及锂业务和民爆业务 两大板块,其中民爆业务又分为民爆生产经营、爆破、运输三大类业务。主营业务收入构成为：锂盐产 品51.54%，民爆产品及爆破服务42 ...

今年以来易普力已经1次登上龙虎榜，最近一次登上龙虎榜为7月23日。 11月18日，易普力盘中下跌2.06%，截至14:28，报13.76元/股，成交8832.51万元，换手率0.91%，总市 值170.68亿元。 资金流向方面，主力资金净流出652.79万元，特大单买入108.36万元，占比1.23%，卖出123.58万元，占 比1.40%；大单买入932.01万元，占比10.55%，卖出1569.58万元，占比17.77%。 易普力今年以来股价涨18.11%，近5个交易日跌2.62%，近20日涨2.99%，近60日跌1.36%。 截至9月30日，易普力股东户数3.36万，较上期减少6.71%；人均流通股20870股，较上期增加7.19%。 2025年1月-9月，易普力实现营业收入73.56亿元，同比增长16.70%；归母净利润6.44亿元，同比增长 22.91%。 分红方面，易普力A股上市后累计派现8.91亿元。近三年，累计派现5.77亿元。 责任编辑：小浪快报 资料显示，易普力股份有限公司位于湖南省长沙市岳麓区谷苑路389号科研楼，成立日期2001年8月10 日，上市日期2006年12月22日，公司主营业 ...

责任编辑：小浪快报 资料显示，山西同德化工股份有限公司位于山西省河曲县文笔镇焦尾城大茂口，成立日期2001年6月10 日，上市日期2010年3月3日，公司主营业务涉及制造销售硝铵、乳化、粉乳炸药、二氧化硅系列产品、 助剂产品、工程爆破设计施工及爆破技术咨询服务(限分支机构使用)、进出口本企业所需的原辅材料、 仪器、仪表及零配件(国家禁止进品的品种除外)并为本企业生产的产品使用技术咨询服务、售后服务。 主营业务收入构成为：工程爆破58.58%，工业炸药27.98%，其他民爆器材10.46%，供应链服务1.10%， 运输服务0.72%，电力业务0.62%，其他0.54%。 同德化工所属申万行业为：基础化工-化学制品-民爆制品。所属概念板块包括：低价、微盘股、小盘、 多晶硅、民爆等。 截至11月10日，同德化工股东户数2.41万，较上期增加7.20%；人均流通股13592股，较上期减少 6.71%。2025年1月-9月，同德化工实现营业收入3.31亿元，同比减少20.53%；归母净利润-993.70万元， 同比减少125.28%。 分红方面，同德化工A股上市后累计派现4.44亿元。近三年，累计派现7473.00万元 ...

Group 1: China Construction - The total new contracts signed by China Construction from January to October reached 3.61 trillion yuan, representing a year-on-year increase of 1% [1] Group 2: Changyuan Power - Changyuan Power's subsidiary received approval for the 100MW wind power project in Songzi, Hubei [2] Group 3: China Metallurgical Group - China Metallurgical Group reported a total new contract amount of 845.07 billion yuan from January to October, a decrease of 11.8% year-on-year, while overseas contracts increased by 7.3% to 71.16 billion yuan [4] Group 4: Shapuaisi - Shapuaisi received approval for clinical trials of deoxycorticosterone ketone solution, intended for use during cataract surgery [5] Group 5: Jianfeng Group - Jianfeng Group's subsidiary received approval for clinical trials of a new drug for treating advanced non-squamous non-small cell lung cancer [7] Group 6: Chongqing Steel - Chongqing Steel announced the resignation of its president Meng Wenwang due to work adjustments [8] Group 7: Tianma Technology - Tianma Technology reported an output of approximately 1732.99 tons of eel in October, with a total output of about 15218.73 tons from January to October [10] Group 8: Qingyuan Co. - Qingyuan Co.'s controlling shareholder reduced holdings of convertible bonds by 685,400 units, accounting for 13.71% of the total issuance [11] Group 9: Spring Airlines - Spring Airlines reported a passenger turnover of 506,200.49 million kilometers in October, a year-on-year increase of 20.06% [12] Group 10: China Merchants Port - China Merchants Port reported a total container volume of 17.1714 million TEUs from January to October, a year-on-year increase of 5.1% [13] Group 11: Yangdian Technology - Yangdian Technology announced a change in control following a share transfer [15] Group 12: Wanfu Biology - Wanfu Biology decided to postpone the implementation of its Knowledge City production base project [16] Group 13: Iwu Biology - Iwu Biology terminated the research project for a specific drug, which will reduce its 2025 net profit by approximately 333.79 million yuan [17] Group 14: Hainan Rubber - Hainan Rubber received an insurance payout of 22.9241 million yuan due to revenue loss from rubber price fluctuations [19] Group 15: Xinjiang Tianye - Xinjiang Tianye plans to establish a joint venture with Tianchi Energy to develop coal chemical projects [20] Group 16: China Coal Energy - China Coal Energy's executive director and president Zhao Rongzhe resigned due to reaching retirement age [22] Group 17: Huading Co. - Huading Co. received approval for a stock issuance to specific investors from the Shanghai Stock Exchange [24] Group 18: Zhongmu Co. - Zhongmu Co. decided to waive its right of first refusal for a 4.04% stake in a subsidiary [25] Group 19: Tianlong Co. - Tianlong Co. reported that its subsidiary's stock issuance was approved by the Beijing Stock Exchange [26] Group 20: Hualan Co. - Hualan Co.'s subsidiary plans to invest 20 million yuan in a biotechnology company [27] Group 21: Haichen Pharmaceutical - Haichen Pharmaceutical received a drug registration certificate for a new injection [28] Group 22: Aier Eye Hospital - Aier Eye Hospital plans to invest 300 million yuan in wealth management products [29] Group 23: Xiamen Engineering Machinery - Xiamen Engineering Machinery announced a planned share reduction by a major shareholder [30] Group 24: Guotai Group - Guotai Group successfully acquired 100% of a mining technology company for 110.1 million yuan [31] Group 25: Wanfeng Aowei - Wanfeng Aowei reached a settlement regarding an arbitration matter with a subsidiary [32] Group 26: Taihe Technology - Taihe Technology is undergoing technical upgrades for its ethylene carbonate project [33] Group 27: Renhe Pharmaceutical - Renhe Pharmaceutical's controlling shareholder plans to reduce holdings by 0.21% [34] Group 28: Changshu Bank - Changshu Bank's second-largest shareholder increased its stake to 3.98% [35] Group 29: Overseas Chinese Town A - Overseas Chinese Town A reported a 57% decrease in contract sales in October [36] Group 30: Canadian Solar - Canadian Solar's controlling shareholder expects total revenue of 1.3 to 1.5 billion USD in Q4 2025 [38] Group 31: Zhonggong Education - Zhonggong Education's controlling shareholder's shares will be auctioned due to a loan dispute [40] Group 32: Aikexibo - Aikexibo's shareholders plan to reduce their holdings by up to 3% [42] Group 33: Wanhua Chemical - Wanhua Chemical's shareholder plans to reduce holdings by up to 0.5% [44] Group 34: Jujie Microfiber - Jujie Microfiber's controlling shareholder plans to reduce holdings by up to 2% [45] Group 35: Wangsu Technology - Wangsu Technology's shareholder plans to reduce holdings by up to 1% [46] Group 36: Tianli Lithium Energy - Tianli Lithium Energy received a patent for lithium-ion battery materials [47] Group 37: Heshun Electric - Heshun Electric won a 40 million yuan project for energy storage services [49] Group 38: Changchun High-tech - Changchun High-tech's subsidiary received FDA approval for a clinical trial of a new drug [51] Group 39: Dongrui Co. - Dongrui Co. received an additional export quota for live pigs to Hong Kong [52] Group 40: Zhongwei Co. - Zhongwei Co. set the H-share issuance price at 34 HKD per share [53] Group 41: Fospower Technology - Fospower Technology plans to invest in a lithium sulfide project with partners [54]

Core Viewpoint - Yahua Group's stock price has shown significant growth this year, with a year-to-date increase of 85.51%, indicating strong market performance and investor interest [1][2]. Group 1: Stock Performance - As of November 14, Yahua Group's stock price was 21.63 CNY per share, with a market capitalization of 24.93 billion CNY [1]. - The stock experienced a decline of 2.04% during the trading session, with a trading volume of 780 million CNY and a turnover rate of 3.37% [1]. - The stock has seen a net outflow of 28.96 million CNY from major funds, with significant buying and selling activity from large orders [1]. Group 2: Financial Performance - For the period from January to September 2025, Yahua Group reported a revenue of 6.047 billion CNY, representing a year-on-year growth of 2.07% [2]. - The net profit attributable to shareholders was 334 million CNY, showing a substantial increase of 116.02% compared to the previous year [2]. Group 3: Business Segments - Yahua Group's main business segments include lithium products (51.54% of revenue) and civil explosives (42.81% of revenue), with transportation services contributing 5.66% [2]. - The company operates in the basic chemical industry, specifically in chemical products and civil explosive products [2]. Group 4: Shareholder Information - As of November 10, the number of shareholders in Yahua Group was 104,000, a decrease of 7.14% from the previous period [2]. - The average number of tradable shares per shareholder increased by 7.69% to 10,178 shares [2]. - The company has distributed a total of 1.24 billion CNY in dividends since its A-share listing, with 622 million CNY distributed in the last three years [3].

Group 1 - China Pacific Insurance's subsidiary, China Pacific Life, reported a cumulative premium income of 241.32 billion yuan for the first ten months, a year-on-year increase of 9.9% [1] - China Pacific Property Insurance, another subsidiary, achieved a cumulative premium income of 173.57 billion yuan, with a year-on-year growth of 0.4% [1] - Nocera Biopharma reported a net loss of 64.41 million yuan for the first three quarters, despite a revenue increase of 59.85% to 1.115 billion yuan [1] Group 2 - Founder Securities received approval from the China Securities Regulatory Commission to issue short-term corporate bonds not exceeding 5 billion yuan [1] - Haicheng Bonda's director plans to reduce his stake by up to 0.97%, equating to 198,400 shares [1] - Yuyuan Group intends to repurchase shares worth between 200 million and 300 million yuan, with a maximum price of 8.60 yuan per share [1] Group 3 - Huaren Shuanghe's subsidiary passed the GMP compliance inspection for a specific diabetes medication [4] - Lichong Group received project notifications from three international automotive manufacturers, with expected sales amounting to approximately 1.135 billion yuan [6] - Deyang Co. is planning to issue H-shares and list on the Hong Kong Stock Exchange to enhance its global strategy [7] Group 4 - Longxin General announced the transfer of its entire stake in a subsidiary for 105.6 million yuan, and also plans to divest another stake for 1 yuan due to poor performance [16] - Kangda New Materials decided to terminate the acquisition of a semiconductor company due to unsatisfactory due diligence progress [17] - Lu'an Environmental reported a 3.28% year-on-year increase in coal sales for October, totaling 3.78 million tons [18] Group 5 - Shanghai Port Group plans to invest 2 billion yuan to establish a new holding company with several state-owned enterprises [20] - Borui Pharmaceutical's new drug for obesity treatment has received clinical trial approval [23] - Silver Dragon Co. has completed the registration of a new energy industry fund focusing on high-growth potential projects [24] Group 6 - Hengrui Medicine received approval for a clinical trial of a prostate cancer drug [11] - Baiji Shenzhou reported a net profit of 1.139 billion yuan for the first three quarters, marking a turnaround from losses [36] - Huasheng Pharmaceutical's special medical food product has received registration certification [60]

11月13日，广东宏大盘中上涨2.01%，截至10:02，报39.05元/股，成交8031.90万元，换手率0.32%，总 市值296.78亿元。 资金流向方面，主力资金净流入1126.17万元，大单买入2121.49万元，占比26.41%，卖出995.32万元， 占比12.39%。 广东宏大今年以来股价涨51.15%，近5个交易日跌1.29%，近20日跌2.33%，近60日涨11.25%。 今年以来广东宏大已经1次登上龙虎榜，最近一次登上龙虎榜为9月19日。 广东宏大所属申万行业为：基础化工-化学制品-民爆制品。所属概念板块包括：并购重组、军民融合、 航天军工、中盘、基金重仓等。 截至10月31日，广东宏大股东户数2.44万，较上期增加0.08%；人均流通股27047股，较上期减少 0.08%。2025年1月-9月，广东宏大实现营业收入145.52亿元，同比增长56.95%；归母净利润6.53亿元， 同比增长0.54%。 分红方面，广东宏大A股上市后累计派现22.48亿元。近三年，累计派现12.88亿元。 机构持仓方面，截止2025年9月30日，广东宏大十大流通股东中，香港中央结算有限公司位居第三大流 通股 ...

11月11日，广东宏大盘中下跌2.06%，截至13:25，报37.98元/股，成交2.10亿元，换手率0.83%，总市值 288.65亿元。 资金流向方面，主力资金净流入385.51万元，特大单买入1782.50万元，占比8.48%，卖出2421.09万元， 占比11.51%；大单买入4186.70万元，占比19.91%，卖出3162.61万元，占比15.04%。 广东宏大今年以来股价涨47.01%，近5个交易日跌7.05%，近20日跌9.23%，近60日涨3.79%。 广东宏大所属申万行业为：基础化工-化学制品-民爆制品。所属概念板块包括：并购重组、军民融合、 中盘、航天军工、基金重仓等。 截至10月31日，广东宏大股东户数2.44万，较上期增加0.08%；人均流通股27047股，较上期减少 0.08%。2025年1月-9月，广东宏大实现营业收入145.52亿元，同比增长56.95%；归母净利润6.53亿元， 同比增长0.54%。 分红方面，广东宏大A股上市后累计派现22.48亿元。近三年，累计派现12.88亿元。 机构持仓方面，截止2025年9月30日，广东宏大十大流通股东中，香港中央结算有限公司位居第三 ...

Group 1 - Huayang Intelligent's shareholder, Fosun Weiying, plans to reduce its stake by up to 285.42 million shares, representing no more than 5% of the company [1] - Kangtai Biological's controlling shareholder's concerted actor, Du Xinglian, intends to reduce its stake by up to 272.4 million shares, which is no more than 0.24% of the total share capital [2] - Mindray Medical has submitted an application for H-share issuance and listing on the Hong Kong Stock Exchange [4] Group 2 - Junpu Intelligent's chairman, Liu Yuan, resigned for personal reasons, and Wang Jianfeng was elected as the new chairman [6] - Mingchen Health's actual controller and executives plan to collectively reduce their stake by up to 8.61 million shares, accounting for 3.27% of the total share capital [7] - Zhongheng Design's directors and executives plan to reduce their stake by up to 151.57 million shares, representing no more than 0.55% of the total share capital [9] Group 3 - ST Erya and its actual controller, Zheng Jiping, are still under investigation by the China Securities Regulatory Commission [10] - Qicai Chemical's shareholder, Beijing Fengyan, plans to reduce its stake by up to 399.12 million shares, accounting for 0.98% of the total share capital [11] - Aier Eye Hospital plans to distribute a cash dividend of 0.8 yuan per 10 shares to all shareholders, totaling approximately 744 million yuan [12] Group 4 - Meiri Interactive's actual controller's concerted actor plans to reduce its stake by up to 394.74 million shares, which is 1% of the total share capital [13] - Maipu Medical's pre-IPO shareholder plans to reduce its stake by up to 67.05 million shares, representing no more than 1% of the total share capital [15] - Qinchuan Machine Tool's subsidiary plans to increase its registered capital from 50 million yuan to 200 million yuan, introducing new investors [17] Group 5 - Guiyang Bank's proposed director, Yu Rui, has resigned due to work reasons [19] - Guiyang Bank plans to acquire Xifeng Development Village Bank and establish a branch [20] - Aojing Medical's directors and executives plan to collectively reduce their stake by up to 25.28 million shares, accounting for no more than 0.19% of the total share capital [21] Group 6 - Zhongji Xuchuang intends to issue H-shares and list on the Hong Kong Stock Exchange [22] - ST Huatuo's stock will have its risk warning lifted, changing its name to Shiji Huatuo [25] - *ST Gaohong's stock has been delisted from the Shenzhen Stock Exchange [27] Group 7 - Tianwo Technology plans to publicly transfer a 7.12% stake in Qinghai Haihe Railway Transportation Co., with an assessed value of approximately 8.54 million yuan [28] - Xingye Technology's major shareholder plans to reduce its stake by up to 886.65 million shares, representing no more than 3% of the total share capital [29] - Jiangnan Chemical has successfully acquired 100% equity of Chongqing Shun'an Explosive Materials Co., with a transfer base price of 1 billion yuan [31]